Delivery Order SPE2DB24D2205-SPE2DB25FEGWA
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $13,397.27 on August 12, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. This firm fixed price delivery order, with an ultimate completion date of August 13, 2025, carries no set-aside designation and represents a competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This firm fixed price delivery order, valued at $3,789.19, represents a competitively awarded contract with no set-aside designation and is scheduled for completion by July 31, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5mL, a meningococcal conjugate vaccine, with a ceiling value of $1,613.15. This firm fixed-price delivery order, which is set to be completed by August 8, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,927.28 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Menveo (1 vial A-C-Y-W-135-DIP, 0.5mL), a meningococcal vaccine product. The contract represents a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,152.10 to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine procurement action supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccine product with a ceiling value of $3,659.10. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, utilizing AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The order is scheduled...
- The Defense Logistics Agency (DLA) awarded a $61,593.00 delivery order to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial A-C-Y-W-135-DIP (0.5ML), a meningococcal vaccine product. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 1, 2025, and was competitively awarded without any set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $14,403.86 to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This competitively awarded, firm fixed-price delivery order was issued on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a standard transactional award under...
- The Defense Logistics Agency awarded a $20,877.50 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Menveo (meningococcal vaccine) in single-dose vial formulation (0.5 mL). This firm fixed-price contract, with an ultimate completion date of August 5, 2025, represents a non-set-aside competitive award supporting federal medical procurement needs. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $168,342.66 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a conjugate meningococcal vaccine. This firm fixed-price, non-set-aside delivery order is scheduled for ultimate completion on August 14, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The award represents a competitive procurement supporting the federal...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGWADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $123,186.00 to AmerisourceBergen Drug Corp for the supply of Menveo 1 vial (a combination meningococcal vaccine) on August 27, 2025, with completion targeted for August 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as a child contract under its larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This delivery order represents a discrete pharmaceutical supply transaction within AmerisourceBergen's comprehensive global pharmaceutical support vehicle with the Defense Logistics Agency. The IDC serves military healthcare systems and other federal agencies by providing access to a broad range of pharmaceutical products, vaccines, and medical supplies across multiple therapeutic domains. AmerisourceBergen's successful track record in meeting DLA requirements through competitive procurement, coupled with its substantial prime vendor contract, positions it as a key supplier for military medical logistics and defense health operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $123.2k | 8/27/25 |